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Host factorsTraditional functions of DExD/H-box helicases are concerned with RNA metabolism; they have been shown
to play a part in nearly every cellular process that involves RNA. On the other hand, it is accepted that
DexD/H-box helicases also engage in activities that do not require helicase activity. A number of DExD/
H-box helicases have been shown to be involved in anti-viral immunity. The RIG-like helicases, RIG-I,
mda5 and lgp2, act as important cytosolic pattern recognition receptors for viral RNA. Detection of viral
nucleic acids by the RIG-like helicases or other anti-viral pattern recognition receptors leads to the induction
of type I interferons and pro-inflammatory cytokines. More recently, additional DExD/H-box helicases have
also been implicated to act as cytosolic sensors of viral nucleic acids, including DDX3, DDX41, DHX9,
DDX60, DDX1 and DHX36. However, there is evidence that at least some of these helicases might have
more downstream functions in pattern recognition receptor signalling pathways, as signalling adaptors or
transcriptional regulators. In an interesting twist, a lot of DExD/H-box helicases have also been identified
as essential host factors for the replication of different viruses, suggesting that viruses ‘hijack’ their RNA
helicase activities for their benefit. Interestingly, DDX3, DDX1 and DHX9 are among the helicases that are re-
quired for the replication of a diverse range of viruses. This might suggest that these helicases are highly
contested targets in the ongoing ‘arms race’ between viruses and the host immune system. This article is
part of a Special Issue entitled: The Biology of RNA helicases — Modulation for life.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
DExD/H-box helicases are part of the large SF2 helicase superfam-
ily. Within the DExD/H-box family, helicases are further distinguished
based on the amino acid sequence of the eponymous conserved
helicase motif II (DEAD, DEAH, DExH and DExD helicases). DExD/
H-box helicases share (at least) eight conserved motifs that are in-
volved in ATP binding, ATP hydrolysis, nucleic acid binding, and
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mains connected by a flexible linker region [1,2]. This structural fold
facilitates the motor protein function associated with helicase activi-
ty. In general, SF2 helicases display an ‘open conformation’ when
they are not bound to a nucleic acid substrate, where the two do-
mains can quite flexibly rotate around the linker. The ATP binding
site is located in the cleft between the two domains and the nucleic
acid binding sites stretch across both domains. When ATP and a
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and hydrolysis. ATP hydrolysis is likely associated with the release
of the nucleic acid substrate [1–4].
Apart from the conserved functional core, most DExD/H-box
helicases contain additional variable N- and C-terminal regions that
confer functional specificity to individual helicases. For example,
these extended regions have been shown to modulate enzymatic ac-
tivity, to contain additional RNA-binding domains or to provide
docking sites for protein–protein interactions [5].
In recent years it has emerged that several DExD/H-box helicases
contribute to anti-viral immunity, either by acting as sensors for viral
nucleic acids or by facilitating downstream signalling events. In general,
pathogens are detected by innate immune cells with the help of
germline-encoded pattern recognition receptors (PRRs) that recognise
conserved structures present in certain pathogen classes, known as
pathogen-associated molecular patterns (PAMPs) [6]. Viral PAMPs are
mainly nucleic acids, including viral genomic RNA and DNA, as well as
replication intermediates [7]. Double-stranded (ds)RNA, in particular,
has long been recognised as a viral PAMP and is detected by several cel-
lular dsRNA-binding proteins [8]. Themain groups of PRRs sensing viral
nucleic acids are endosomal Toll-like receptors (TLRs), the RIG-like
helicases (RLHs) which are part of the DExH family of RNA helicases,
and cytoplasmic DNA receptors [8]. In addition, several DExD/H-box
helicases that are not part of the RIG-I family have recently been impli-
cated in the sensing of viral nucleic acids and/or downstream signalling
pathways [9–14]. A general characteristic of anti-viral PRR signalling is
the induction of type I interferons (IFN-α and IFN-β), cytokines with
potent anti-viral activity. Their anti-viral activity is largely mediated
by interferon-stimulated genes (ISGs) that encode proteins with direct
anti-viral effector functions [15]. Activation of the transcription factors
IRF3 or IRF7 is required for induction of type I interferons [16], and sig-
nalling pathways downstream of antiviral PRRs engage kinases that
phosphorylate and activate IRF3/7. TLR3, the RLHs andmost DNA recep-
tors discovered to date utilise the IKK-related kinases TBK1 and IKKε for
phosphorylation of IRF3/7 [17–21]. Their upstream signalling pathways
are quite divergent: TLR3 depends on the TIR-domain containing adap-
tor molecule TRIF [22], the RLHs utilise a CARD-domain containing mi-
tochondrial adaptor called MAVS (also called IPS-1, Cardif or VISA)
[18,23–25], and most cytosolic DNA receptors depend on an
ER-resident adaptor molecule called STING [26].
TLR7 and TLR9 engage a different signalling pathwaywhich depends
on the TIR-adaptor molecule MyD88 and the kinases NIK and IKKα for
phosphorylation and activation of IRF7 [27,28]. This pathway is mainly
active in plasmacytoid dendritic cells (pDCs), which express TLR7 and
TLR9 and constitutively high levels of IRF7, allowing them to produce
high levels of IFN-α in an early response to viral infections [29].
Several DExD/H-box helicases that are not part of the RIG-I family, in-
cluding DDX3, DDX60, DDX41, DDX1, DHX9 and DHX36, have recently
been implicated as additional receptors for viral nucleic acids, and to in-
duce IFN induction via TIR adaptor — or MAVS-dependent signalling
[9–14].
Because type I interferons are such potent anti-viral cytokines,
many viruses have evolved strategies for interfering with their induc-
tion [30,31]. In fact, we know numerous examples of viral immune
evasion proteins that either mask viral RNA ligands or directly inhibit
the RLHs or downstream signalling molecules involved in type I IFN
induction [32,33]. In many cases, the study of such viral immune eva-
sion proteins has led to new insights into components of the host
anti-viral immune response [33].
Intriguingly, apart from their roles in viral recognition and anti-viral
immunity, RNA helicases are also actively recruited by viruses to facili-
tate their replication cycles. Interestingly, while all pro- and eukaryotic
genomes contain RNA helicase genes, a lot of viruses do not seem to en-
code their own RNA helicases. This suggests that viruses rely heavily on
host RNA helicases to mediate RNA remodelling events that are part of
their replication cycle or required for viral gene expression. As such,several DExD/H-box helicases have been identified as essential host fac-
tors for the replication of different viruses, including those that pose
major global health threats, such as HIV and Hepatitis C Virus (HCV).
It is fascinating that in many cases the very same RNA helicases that
are ‘hijacked’ by viruses as essential host factors are also the ones impli-
cated in anti-viral innate immune responses. This might indicate that
RNA helicases are in fact at the very centre of an ongoing evolutionary
‘arms race’ between viruses and the host immune system.2. RNA helicases in innate anti-viral immunity
2.1. The RIG-like helicases
The RIG-like helicases (RLHs), RIG-I, mda5 and lgp2, are part of the
DExH RNA helicase family, and are recognised as one of themost impor-
tant groups of anti-viral PRRs [34]. In contrast to other DExD/H-box
helicases that have recently been implicated in anti-viral immunity
(discussed below), RIG-I and mda5 contain CARD signalling domains
[35] that allow them to interact with the mitochondrial CARD-domain
containing adaptor molecule MAVS [24]. In addition to the N-terminal
tandem CARD domains and the central helicase core region comprising
the conserved two RecA-like domains, RLHs also contain a C-terminal
regulatory domain (CTD or RD) which mediates specific recognition of
viral RNAs [36,37]. Intensive research over the last few years has defined
the RNA ligands for RIG-I. It is nowwidely accepted that RIG-I bindswith
high affinity to blunt-ended RNAs containing a free 5′ triphosphate end
(5′ppp), followed by a short double stranded region of at least 19 bp
[38]. Studies in Influenza and Sendai virus-infected cells have confirmed
these requirements and demonstrated that RIG-I stimulatory activity
resides primarily in progeny viral genomes, which contain a 5′ppp and
adopt so-called ‘panhandle’ structures through intramolecular base-
pairing [39,40]. Baum et al. identified SeV defective interfering (DI)
copy-back genomes as particularly strong RIG-I ligands in SeV infected
cells. These DI genomes consist of a 546-nt RNA molecule with a 5′ppp
and a 92nt long perfect dsRNA portion [39]. Recent structural studies
have also provided a lot of insights into ligand binding and activation
of the RLHs. Specificity of 5′ppp binding is mostly conferred by the
CTD, while the helicase core region binds to the double-stranded part
of the RNA ligand. This binding does not confer sequence specificity, as
contacts are made exclusively with the phosphoribose backbone of the
RNA [41]. Initial binding of the 5′ppp end to the CTD appears to allow
for subsequent cooperative binding of the double-stranded region of
the RNA and ATP to the helicase core domain [42].
This binding results in a conformational change to the typical ‘closed
form’ of DExD/H-box helicases that allows for efficient ATP hydrolysis
[42,43]. It has been shown that RIG-I exists in an ‘auto-inhibited’ confor-
mation in the absence of RNA [37,44], where the CARD domains are not
accessible due to an internal interaction between the second CARD do-
main and the second RecA-like helicase domain [42,45]. The conforma-
tional change that follows ATP and RNA binding disrupts this internal
interaction and releases the tandem CARD domains [42,43]. The free
CARD domains of RIG-I can then initiate signalling by interacting with
the CARD-domains of the MAVS adaptor molecule [42,46].
RIG-I has also been described to bind to, and be activated by, longer
dsRNA ligands (~100–400 bp) lacking a 5′ppp end. In this case, a num-
ber of RIG-Imolecules seemed to cooperatively assemble side by side on
the dsRNA strand [47]. It is possible that a high concentration of dsRNA
can overcome the initial requirement for 5′ppp binding to the CTD, as
this is believed to facilitate binding of the RNA ligand to the helicase
core region by increasing the local concentration of dsRNA. In addition,
RIG-I can also be activated byRNase L cleavage products of viral and cel-
lular RNAs, which do not contain a 5′ppp end [48]. It is unclear how
RIG-I can recognise these cleavage products, and it will be interesting
to determine whether a co-receptor, such as lgp2 (see below) is re-
quired for this activation.
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the sense of unwinding its double-stranded RNA ligands. It was ini-
tially reported that recombinant RIG-I can unwind short duplexes
containing a 3′overhang [49]. However, RNAs containing a 3′over-
hang were not good IFN-inducers in cells [49], and it is now believed
that RIG-I does not efficiently bind to RNAs with single-stranded
overhangs [50], suggesting that these are not physiological ligands
for RIG-I. It has also been suggested that while RIG-I can translocate
on RNA [51], it might lack a phenylalanine loop motif required for
RNA unwinding [52]. It is therefore possible that RIG-I acts more
like a motor protein by converting the energy from ATP hydrolysis
into a mechanical force that drives the CARD and helicase domains
apart and thereby releases the auto-inhibited state.
The free CARD domains then appear to bind to K63-linked free
polyubiquitin chains and thereby induce tetramerisation of RIG-I. These
higher order complexes of RIG-I and ubiquitin were shown to be strong
inducers of type I IFN [53]. The RIG-I CARD domains can also be directly
ubiquitinated by Trim25 [54], which should sterically prevent them from
interactingwith the helicase domain to re-instate the autoinhibited state
[42]. Recently, it has been shown that the 14-3-3ε chaperone protein is
involved in facilitating a stable TRIM25-RIG-I interaction and shuttling
of the RIG-I complex to themitochondrial membranewhere it can inter-
act with MAVS [55]. It has become clear in recent years that organelle
membrane reorganisation events are closely linked with the induction
of innate immune signalling pathways. Mitochondrial fusion events
[56,57], as well as interactions between mitochondria, mitochondria-
associatedmembranes (MAMs) and peroxisomes [58] seem to be neces-
sary to achieve signalling through MAVS. Also, a recent study showed
that the signalling molecule TRAF3 normally resides in ER-associated
compartments and the cis-Golgi, while smaller TRAF3-containing
speckles appeared following virus infection [59]. Translocation of
TRAF3 to mitochondria was mediated by Sec16a and p115, proteins
that function in ER-to-Golgi vesicle transport. Knockdown of these pro-
teins inhibited dsRNA-induced IFN induction, showing that this translo-
cation of TRAF3 is crucial for assembly of MAVS-signalling complexes
[59]. TRAF3 is required for IRF3/7 activation downstream of anti-viral
PRRs and consequently for the induction of type I interferons [60].
The other two members of the RLH family, Mda5 and lgp2, are not
as well characterised as RIG-I. Mda5 has been implicated in the re-
sponse to long synthetic dsRNA (poly(I:C)), and appears to mediate
responses to distinct sets of viruses compared with RIG-I. Mda5 has
mainly been implicated in the response to picornaviruses, vaccinia
virus and reovirus [61–65]. It has been suggested that mda5 recog-
nises particularly large and branched RNA structures termed ‘RNA
webs’ that are produced during the replication of certain viruses,
such as EMCV (a picornavirus) and vaccinia virus [66].
The CTDs of mda5 and lgp2 are structurally very similar to the CTD
of RIG-I. However, while they also mediate binding to blunt-ended
dsRNA molecules, the CTDs of mda5 and lgp2 have no specificity for
5′ppp ends [67,68]. The lgp2 CTD, but not the mda5 CTD, also appears
to mediate the same autoinhibited state that has been described for
RIG-I [69]. From the structure of the mda5 CTD it is initially unclear
why mda5 is preferentially activated by long dsRNA [67]. In this con-
text, it is interesting to note that the CTD of mda5 has a much lower
affinity for dsRNA molecules than the CTDs of RIG-I and lgp2 [67].
Thus, it is interesting that mda5 appears to cooperatively assemble
on dsRNA filaments, similar to what had been described for RIG-I ac-
tivation by longer dsRNAs without a 5′ppp. This cooperative assembly
of mda5 might overcome the initial low affinity of its CTD for dsRNA,
although it has been questioned whether the CTD is required for RNA
binding at all [70]. The CTD appears to be required for cooperative as-
sembly of mda5 filaments on dsRNA, possibly through mediating an
intermolecular interaction with another mda5 molecule [70,71]. In
any case, the ensuing mda5-coated RNA filaments appear to be well
suited to induce oligomerisation of MAVS via CARD-CARD interac-
tions [70–72].Lgp2 displays a similar helicase core and CTD as RIG-I and mda5,
but lacks the CARD signalling domains [35]. Due to its lack of signal-
ling domains, it was initially believed to be an inhibitory RLH and
overexpression of lgp2 indeed suppressed RIG-I signalling [73]. Stud-
ies on lgp2 knockout mice however offered a more differentiated
view of the role of lgp2 [74–77]. They provide evidence that lgp2 en-
hances mda5-dependent IFN induction in response to picornavirus
infection. As the affinity of the mda5 CTD for dsRNA is relatively
low, lgp2 might serve as a co-receptor that facilitates RNA binding
to mda5, e.g. by increasing the local concentration of suitable RNA li-
gands [74,75]. It has recently been shown that the basal ATP hydroly-
sis activity displayed by lgp2, which distinguishes it from mda5 and
RIG-I, is required for enhanced binding of lgp2 to dsRNA, in particular
to imperfect dsRNA substrates containing noncomplementary bulges
[78]. The authors showed that this basal ATP hydrolysis activity of
lgp2 was required for its enhancement of mda5-mediated IFN induc-
tion, suggesting that lgp2 might bind to dsRNA first before sensitizing
mda5 to these RNA ligands [78]. The extent of lgp2 involvement in
mda5 signalling might depend on the nature of the dsRNA ligand,
e.g. its overall length and the presence of secondary structures, such
as bulges and hairpins.
The effects of lgp2 on RIG-I signalling appear to be even more com-
plex and might also depend on the exact nature of the RNA ligand. As
mentioned above, lgp2was initially described to inhibit RIG-I signalling
through an interaction between its CTD and the helicase domain of
RIG-I [69,73]. In keeping with this, Lgp2 knockout mice were shown
to display enhanced IFN production to VSV infection [74], and endoge-
nous lgp2 limited the responses to seasonal influenza virus strains
that activate IRF3 and induce IFN [77]. However, another study sug-
gested that loss of lgp2 leads to defects in RIG-I-mediated VSV and
Sendai virus recognition [75]. Lgp2 also appears to be required for re-
sponses to cytoplasmic poly(dA:dT) DNA, Listeria monocytogenes and
vaccinia virus, which are likely mediated by RIG-I ligands generated
through RNA polymerase III activity [76]. This controversial data on
the relationship between RIG-I and lgp2 might suggest that lgp2 can
act as both an inhibitor and activator of RIG-I, possibly depending on
the nature of the RNA ligand and the cellular concentration of lgp2. It
will require further investigations to understand whether and how
lgp2 positively and negatively modulates RIG-I-dependent responses
to different dsRNA ligands, and also how exactly it enhances mda5 rec-
ognition of dsRNA.
2.2. DDX3
DDX3 has two homologues, DDX3X and DDX3Y, that were first de-
scribed in 1997 in a study of the non-recombining region of the Y chro-
mosome [79]. DDX3X is ubiquitously expressed in most tissues, while
expression of the DDX3Y protein appears to be restricted to the male
germline [80]. Like many DEAD-box helicases, DDX3(X) has been
implicated in various different aspects of RNA metabolism, including
transcriptional regulation, splicing, mRNA export, ribosome biogenesis
and translational regulation [81]. It has been suggested to regulate tran-
scription of the E-Cadherin, p21/waf and ifnb promoters [82–84], and
recent studies appear to manifest a role for DDX3 in translational regu-
lation, in particular for mRNAs with complex 5′UTRs [85,86].
Two simultaneous reports in 2008 provided the first evidence that
DDX3 is a component of anti-viral innate immune signalling path-
ways [84,87]. The study wewere involved in identified DDX3 as a mo-
lecular host target of the vaccinia virus protein K7. K7 inhibited ifnb
induction at the level of IKKε and TBK1, the two key kinases that
phosphorylate IRF3/7 downstream of TLR3, TLR4, the RLHs, and
most known cytoplasmic DNA receptors. We showed that DDX3
interacted with IKKε after Sendai virus stimulation and that it en-
hanced induction of the ifnb promoter [87]. The intrinsically unstruc-
tured N-terminal region of DDX3 was required for this activity, but its
ATPase and RNA unwinding activities were not [87]. The second
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phosphorylation target of, TBK1. TBK1-mediated phosphorylation of
DDX3 was shown to be required for the effect of DDX3 on the ifnb
promoter [84]. This study therefore also supported a role for DDX3
in ifnb promoter induction downstream of TBK1/IKKε. However, the
authors also demonstrated that DDX3 was recruited to the ifnb pro-
moter enhancer region, suggesting that DDX3 acts as a transcriptional
regulator after being activated by TBK1 [84].
Another study also supported a role for DDX3 in the RLH pathway
leading to type I IFN induction, but placed DDX3 upstream of TBK1/
IKKε [13]. Oshiumi et al. demonstrated an interaction between DDX3
andMAVS and suggested that DDX3 acts as a sensor for viral RNA in con-
junctionwith RIG-I andmda5. The authors proposed that DDX3 can sen-
sitize the RLH system for dsRNA ligands at early stages of infectionwhen
levels of the IFN-inducible RIG-I are still low [13]. The same group later
demonstrated that the HCV Core protein, which had previously been
shown to interact with DDX3, can disrupt the MAVS-DDX3 interaction
and thus act as a viral immune evasion protein preventing IFN induction
[88]. Contrary to this, another report suggested thatHCVCore protein ac-
tually triggers IFN induction through DDX3 [89]. Culture-adapted strains
of HCV had acquired mutations in the N-terminal DDX3-binding region
of the Core protein, which lowered their binding affinity for DDX3. This
resulted in reduced TBK1-dependent IFN induction and enhanced repli-
cation of the culture adapted strains [89]. As DDX3 is required for HCV
replication [90,91], the DDX3-HCV Core protein interaction will also be
discussed in this context in Section 3.1.
Several other studies also support a role for DDX3 in ifnb induc-
tion. While it had first been shown that DDX3 interacts with the
HBV polymerase and inhibits HBV reverse transcription [92], two sub-
sequent studies showed that the HBV polymerase acts as a viral im-
mune evasion protein by disrupting the interaction between DDX3
and IKKε/TBK1 [93,94]. This is strongly reminiscent of the way vaccin-
ia virus protein K7 targets DDX3 to prevent induction of ifnb [87].
DDX3 also appears to be involved in IFN-β induction downstream of
the cytoplasmic DNA receptor DAI. DAI-dependent IFN-β induction
in response to Human Cytomegalovirus (HCMV) was greatly dimin-
ished upon knockdown of DDX3 [95].
In summary, these reports clearly implicate DDX3 in anti-viral in-
nate immune signalling pathways leading to type I IFN induction.
However, despite the strength of this evidence, the exact nature of
the involvement of DDX3 in these pathways is not yet clear. Most of
the evidence points to a function as a signalling intermediate down-
stream of TBK1/IKKε [84,87,93–95], however DDX3 also interacts
with MAVS and has been suggested to act as a PRR that senses viral
RNA [13]. Finally, it has also been shown to bind to the ifnb promoter
directly, suggesting it acts as a transcriptional regulator [84].
Our research group has recently confirmed direct interactions be-
tween DDX3 and IKKε, and between DDX3 and the transcription fac-
tor IRF3 [96]. Phosphorylation of DDX3 at serine 102 by IKKε was
required for the recruitment of IRF3 into the complex, and mutation
of serine 102 in DDX3 led to reduced IRF3 activation and ifnb promot-
er induction [96]. We therefore propose that DDX3 acts as a scaffold-
ing adaptor that coordinates the activation of IKKε and its substrate
IRF3 and thereby contributes to ifnb induction.
Future research will have to clarify whether DDX3 can also act as a
direct viral RNA sensor and/or a transcriptional regulator, as these are
also compatible with the described functions of DEAD-box helicases
and are not necessarily mutually exclusive with its role as a signalling
adaptor.
2.3. DDX41
In order to comprehensively address the potential involvement of
other DExD/H-box helicases in innate immunity, Yong-Jun Liu's group
carried out an siRNA screen with 59 members of the DExD/H-box
helicase family. They found that IFN and pro-inflammatory cytokineproduction in response to cytosolic DNA was impaired in murine mye-
loid (m)DCs lacking DDX41 [10]. The authors showed that DDX41
bound specifically to DNA rather than RNA, and that this binding re-
quired theWalker A and Bmotifs of DDX41 [10]. AsWalker motifs usu-
ally mediate ATP binding and hydrolysis, this might indicate that ATP
binding is required for DNA binding by DDX41.
Several other receptors for cytoplasmic DNA have been identified,
including IFI16, DAI, and RNA Polymerase III [97]. IFI16, in particular,
has also been shown to sense viral DNA in human myeloid cells [19].
In fact, in the study by Yong-Jun Liu's group, DDX41 and IFI16 were
both required for the response to cytosolic DNA and DNA viruses in
the human monocytic THP1 cell line [10]. The authors suggested
that the constitutively expressed DDX41 acts as an early sensor of
viral DNA, while IFI16 is upregulated at later stages of viral infections
in a DDX41-dependent manner. Indeed, IFI16 expression was nearly
completely absent in cells lacking DDX41 [10].
The molecule STING has been shown to act as a crucial adaptor mol-
ecule for cytoplasmic DNA receptors [98]. Here, STINGwas also required
for the response to cytosolic DNA, as well as to HSV-1, L. monocytogenes
and adenovirus infection [10]. DDX41 interacted with STING and TBK1
(but not p204, the murine IFI16 orthologue), in keeping with its pro-
posed role as a separate DNA receptor [10]. Another recent publication
confirmed a role for DDX41 in the response to adenovirus infection in
the murine macrophage cell line Raw264.7. In this study, TBK1, STING
and Aim2 were required to induce IRF3 activation in addition to
DDX41, but not DAI or p204 [99]. Aim2 is a cytosolic DNA receptor that
is closely related to IFI16, but has mainly been linked to inflammasome
and Caspase-1 activation, rather than IFN induction [100].
Recently, DDX41 has also been proposed to bind directly to cyclic di-
nucleotides (CDNs), namely cyclic-di-GMP and cyclic-di-AMP [101].
These bacterial second messenger molecules act as PAMPs that signal
the presence of an intracellular bacterial infection and induce a type I
IFN response. DDX41 has been shown to induce a STING-TBK1-IRF3-
dependent type I IFN response, following its binding to CDNs [101]. How-
ever, STING itself can also directly bind CDNs, and it was previously pro-
posed that STING can directly sense the presence of CDNs without the
need for an upstream receptor [102]. More recently, two studies from
the Chen lab described cyclic-GMP-AMP (cGAMP) as a novel second
messenger that is generated in response to cytoplasmic DNA inmamma-
lian cells [103,104]. They identified a nucleotidyltransferase, cGAMP
synthase (cGAS), which generates cGAMP in response to cytosolic DNA
[104]. They implicated cGAS as a universal DNA sensor that triggers the
activation of downstream molecules, such as STING, in a cGAMP-
dependent manner [104]. The respective roles of DDX41 and STING in
CDN sensing remain to be clarified, and also whether direct binding of
cytosolic DNA to these two proteins is required.
There are very few previous reports on cellular functions for DDX41,
but in one such study DDX41 (or ABS, Abstrakt) was suggested to inter-
act with Sorting Nexin-2 (SNX2) [105]. The function of SNX2 is also
largely unclear, but it is part of the retromer complex that shuttles re-
ceptors from endosomes to the trans-Golgi network [106]. It is possible
that SNX2 is also involved in other intracellular trafficking events [107].
As mentioned above, it is becoming increasingly clear that innate im-
mune responses are intricately linked with membrane reorganisation
and vesicle transport events [59,108]. Reminiscent of what was ob-
served for TRAF3, STING appears to traffic from the ER to the Golgi in re-
sponse to cytoplasmic DNA sensing. It eventually assembles with TBK1
in cytoplasmic punctuate structures [108]. Therefore, it is an intriguing
idea that DDX41 might be involved in STING trafficking through its in-
teraction with a sorting nexin; a potential role of DDX41 that might
warrant further investigation.
2.4. DHX9
Yong-Jun Liu's group also identified DHX9 (also known as RNA
Helicase A (RHA) or Nuclear DNA Helicase II (NDHII)) as a sensor
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DNA in plasmacytoid dendritic cells (pDCs) [14]. In myeloid DCs, type
I IFN and pro-inflammatory cytokine production in response to
poly(I:C) was attenuated after knockdown of DHX9. Binding of
DHX9 to poly(I:C) required its two N-terminal double-stranded
RNA-binding domains rather than the helicase core region. The
C-terminus of DHX9 was shown to interact with the CARD domain
of the mitochondrial adaptor MAVS, suggesting that DHX9 links into
the RLH signalling pathway. In fact, either RIG-I or mda5 were also re-
quired for the response to poly(I:C) in addition to DHX9, depending
on the exact nature of the RNA ligand used [9]. In pDCs, DHX9 was
shown to be required for the induction of IFN-α and TNF-α by
CpG-B DNA, in a MyD88-dependent manner (see also Section 2.6)
[14]. There is also additional evidence for a role of DHX9 in innate im-
munity. It is an interferon-inducible gene and has been shown to get
phosphorylated by the dsRNA-binding kinase PKR [109], providing a
link between DHX9 and responses to viral dsRNA in a different con-
text. DHX9 phosphorylation by PKR was investigated in the context
of its requirement for HIV replication and decreased its affinity for
RNA [109] (see also Section 3.3).
DHX9 has been extensively characterised as a transcriptional reg-
ulator, consistent with its mostly nuclear localisation [5]. Interesting-
ly, it was shown that DHX9 is recruited into PML nuclear bodies after
IFN-α-stimulation where it associated with nascent RNA polymerase
II (mRNA) transcripts [110]. This observation suggests that DHX9
might have a role in regulating transcription of IFN-stimulated
genes (ISGs) or subsequent processing of ISG mRNAs [110]. This po-
tential function of DHX9 also clearly implicates DHX9 in anti-viral im-
mune responses, as the anti-viral effects of IFNs are largely executed
by IFN-stimulated genes. In fact, many proteins involved in the detec-
tion of viral infections are themselves interferon-inducible, including
RIG-I, mda5 and IRF7.
In the context of this evidence for one or more functions of DHX9
in antiviral immunity, it is very interesting to note that DHX9 is ac-
tively recruited by many different viruses and required for their rep-
lication (discussed in Section 3.3). This suggests that DHX9might be a
highly contested protein in the battle between viruses and the innate
immune system.
2.5. DDX1/DDX21/DHX36 complex
In yet another publication from Yong-Jun Liu's group, DDX1 was
identified as a dsRNA-sensing receptor [11]. In a pulldown with
poly(I:C) followed by mass spectrometry analysis, DDX1 as well as
DDX21 and DHX36 were identified. The authors then showed that
only DDX1 directly bound to poly(I:C), a slightly unexpected finding
as DHX36 and DDX21 would be expected to bind dsRNA via their con-
served helicase motifs. Instead, DDX21 and DHX36 were placed down-
stream of DDX1. DDX21 bound to both DDX1 and DHX36, suggesting
that it bridges the interaction between these two helicases [11].
DDX21 also interacted with itself, suggesting that the complex might
be a DDX1-DDX21-DDX21-DHX36 complex. Both DDX21 and DHX36
interacted with TRIF, the TIR-adaptor molecule that mediates signalling
downstream of TLR3 and TLR4 [11]. This suggested that DDX1 senses
dsRNA and then triggers signalling via DDX21 and DHX36 to TRIF.
Knockdown of DDX1, DDX21 or DHX36 inhibited IFN induction in re-
sponse to long or short poly(I:C), Influenza Virus and Reovirus [11].
Depending on the nature of the RNA ligand, knockdown of RIG-I,
mda5 or TLR3 also strongly inhibited IFN induction [11].
Previous reports on DDX1 function appeared to point towards a
role for DDX1 in 3′ processing of mRNAs [111,112]. It was shown to
interact with nuclear ribonucleoprotein K, poly(A)-RNA [112], and
Cleavage stimulatory factor (CstF) 64, and to localise to nuclear cleav-
age bodies [111]. In addition, DDX1 was shown to bind to the p65
subunit of the major pro-inflammatory transcription factor NF-κB,
thereby enhancing NF-κB dependent transcription [113].DDX21 was previously identified as nucleolar protein regulating
ribosomal (r)RNA processing. Knockdown of DDX21 inhibited 18S
and 28S rRNA production and slowed down cell proliferation [114],
possibly by inducing cell cycle arrest at the G1/S-Phase [115].
DDX21 (originally named RH-II/GuA) has also been shown to interact
directly with the transcription factor c-jun and to participate in c-jun
mediated transcriptional activation of target genes [116].
DHX36 (also called RHAU or G4R1) is a predominantly nuclear pro-
tein, but appears to shuttle out of the nucleus as part of RNPs. It can be
recruited into stress granules via its N-terminal RNA-binding domain
[117]. It has also been shown to be involved in the degradation of
ARE-containing RNAs [118]. Furthermore, DHX36 has been described
to recognise and remove so-called quadruplex knots in G-rich RNA
and DNA (G4-loops) [119,120]. Its specificity for G4-loops is mediated
by the N-terminal RNA-binding domain of DHX36 rather than its
helicase core region [119]. G4 loops are found in telomeric repeats,
but they also seem to be present in gene promoter regions where they
block transcription [121]. Indeed, DHX36 has been suggested to resolve
G4-loops present in the promoter of the transcriptional regulator YY1
and to thus facilitate its transcription [122]. YY1 has recently been
shown to negatively regulate the ifnb promoter, providing another po-
tential link between DHX36 and anti-viral immunity [123].
As discussed further in Section 2.6, DHX36 has also been sug-
gested to sense CpG-A oligonucleotides in plasmacytoid DCs [14]. As
CpG-A oligonucleotides contain polyG sequences at their 5′ and/or
3′ ends, they might form G4-loops or similar structures that can spe-
cifically be detected by DHX36.
2.6. DHX36 and DHX9 as CpG sensors
As mentioned above, DHX36 was also characterised in a separate
study from Liu's group as a CpG-A binding protein, whereas DHX9
was identified as a CpG-B binding protein [14]. CpG-A and CpG-B oligo-
nucleotides are known to induce IFN-α and proinflammatory cytokine
production through TLR9, with CpG-A inducing stronger IFN-α produc-
tion [124,125]. KnockdownofDHX9orDHX36 reduced IFN-α induction
in response to CpG-A and CpG-B respectively [14]. Knockdown of
Myd88 also completely abolished responses to CpG-A and CpG-B,
suggesting that these helicases signal through a MyD88-dependent
pathway. Indeed, the authors showed that both helicases bound to the
TIR domain of MyD88 [14]. However, knockdown of TLR9 also nearly
completely abolished activation of IRF7 and NF-κB downstream of
CpG-A and CpG-B [14], suggesting that both TLR9 and DHX9/DHX36
are required for CpG sensing in pDCs.
Both DHX9 and DHX36 have previously been described as DNA-
binding proteins, supporting their potential roles as DNA sensors. As
mentioned in Section 2.5, DHX36 was shown to resolve G4 loops in
both DNA and RNA [120]. DHX9 was characterised as a helicase that
could unwind both DNA and RNA [126]. Recently, it has been shown
that DHX9 might in fact also be involved in unwinding unusual DNA
structures, such as intramolecular triplexes [127]. As CpG oligonucleo-
tides contain repetitive regions of GC nucleotides and poly(G) stretches
in the case of CpG-A, they might be prone to forming unusual DNA
structures, such as G4-loops or triplex structures, possibly explaining
the observed binding of DHX9 and DHX36 to these CpG-DNA
oligonucleotides.
The characterisation of DHX9 as a dsRNA (Section 2.4) and CpG-A
sensing protein is intriguing, yet it is also puzzling how the same pro-
tein can detect different nucleic acid ligands and then induce signal-
ling through either MAVS (Section 2.4) or MyD88 depending on the
nature of the ligand and the cell type [9,14]. Similarly, DHX36 is sug-
gested to facilitate signalling through TRIF downstream of DDX1, as
well as acting as a receptor for CpG-B DNA in a MyD88-dependent
manner. Clearly, future studies will have to further ascertain the
exact mechanisms by which both DHX36 and DHX9 contribute to
these innate immune signalling pathways.
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Seya's laboratory recently identified a role for DDX60 in RLH-
mediated signalling. Their study showed that DDX60 acts in conjunc-
tion with RIG-I or mda5 to mediate responses to viral dsRNA [12]. Pro-
duction of IFN-β and the IFN-inducible chemokine IP10 in response to
transfected poly(I:C), Sendai Virus, VSV, Poliovirus or HSV-1 infection
was reduced in cells after DDX60 knockdown. VSV and poliovirus repli-
cation were also reduced following knockdown of DDX60 [12]. While
DDX60 has sequence similarity with the RNA exosome cofactor
SKIV2L and interacted with two exosome components, EXOSC1 and
EXOSC4, the antiviral activity of DDX60 appeared to be independent
of the RNA exosome [12]. Instead, the authors showed that DDX60
interactedwith the RIG-I, mda5 and lgp2 and enhanced their signalling.
In a large screen for the anti-viral activities of ISGs, DDX60 was
also recently shown to have anti-viral activity against HCV [128]. As
HCV genomic RNA is recognised by RIG-I, this report appears to con-
firm a role for DDX60 in the RLH pathway.
Thus, DDX60 was proposed to act as a cofactor for RLH-dependent
detection of dsRNA [12], potentially sensitizing the RLHs for dsRNA. It
will be interesting to address the question whether all RLH-mediated
responses require DDX60 or whether it selectively facilitates the de-
tection of specific RNA (or even DNA) ligands.2.8. Concluding remarks on RNA helicases in innate immunity
While the RIG-like helicases (RLHs) have a clearly established role as
viral RNA sensors in the cytosol, the evidence that other DExD/H-box
helicases can also act as sensors for viral RNA or DNA ligands is still a lit-
tle bit ambiguous. The RLHs recognise their specific RNA ligandsmainly
through their C-terminal regulatory domain and not the conserved
helicase core region. It generally appears to be the case for DExD/
H-box helicases that interactions with specific RNA ligands are mediat-
ed by adjacent additional RNA-binding domains or are facilitated
through interactions with other RNA-binding proteins [2,4]. In their
N-terminal tandem CARD domains, the RLHs also contain a clearly de-
fined signalling domain that allows them to trigger signalling through
a homologous interaction with the CARD-domain containing adaptor
molecule MAVS.
For most other DexD/H-box helicases that have been implicated in
innate immune responses to viral nucleic acids, it is less clear whether
they act as bona fide receptors that initiate signalling in response to
binding viral RNA or DNA. DDX3 has been suggested to act as a recep-
tor for dsRNA [13], yet there is also strong evidence that it functions
downstream of TBK1 and IKKε either as a signalling adaptor and/or
transcriptional regulator [84,87,93–96]. As DexD/H-box helicases
bind to RNA and in some cases also to DNA in a rather indiscriminate
manner via the conserved helicase motifs, it is not unexpected to ob-
serve them interacting with various synthetic or viral nucleic acids.
However, several DExD/H-box helicases, including DDX3 and DHX9,
have additional functions that are independent of their RNA unwind-
ing activity and in many cases also their ATPase activity [5,84,87].
Mere in vitro binding to RNA or DNA should therefore not be sufficient
to characterise a DExD/H-box protein as a nucleic acid sensor.
It might be worth considering that not all of the helicases implicated
in RNA or DNA sensing are independent receptors, but could either act as
co-receptors for established nucleic-acid binding PRRs, play downstream
roles in their signalling pathways or, even more generally, influence the
transcriptional or posttranscriptional regulation of immuno-relevant
genes, such as interferons or interferon-stimulated genes. Thus, it
should be investigated how exactly the newly identified DExD/H-box
helicase nucleic-acid sensing pathways intersect or cooperate with the
established nucleic-acid receptors, such as the RLHs and TLR9. The
current proposed roles for the DExD/H-box helicases described in this
section are summarised in Fig. 1.3. RNA helicases in viral replication
Asmentioned above, not all viruses encode their own RNA helicases
and many cellular helicases have been identified as essential host fac-
tors for viral replication. It appears that viruses rely heavily on host
helicases for RNA unwinding functionality. Presumably, akin to their
numerous functions in the processesmediating eukaryotic gene expres-
sion, RNA helicases are required for equivalent steps during the expres-
sion of viral genes. In addition to that, viruses might require additional
RNA unwinding activity for remodelling genomic RNA structures,
remodelling structures of replication intermediates, or for packaging
their genomic RNA into virions.
The role of RNA helicases in the replication cycles of different virus
classes has not been systematically addressed. However siRNA screens
continue to identify DExD/H-box helicases as essential cofactors for
the replication of individual viruses, and proteomics screens with viral
proteins as baits often identify interacting DExD/H-box helicases. We
will focus here on the DExD/H-box helicases that appear to have an ob-
vious dual function as viral replication cofactors and innate immune
mediators, namely DDX3, DDX1 and DHX9. For a more comprehensive
overview of the roles of RNA helicases in viral replication, we direct the
reader towards a recent review by Ranji and Boris–Lawrie [129]. The
role of RNA helicases in HIV infection has also recently been reviewed
in detail [130].
3.1. DDX3
In Section 2.2, we have described how viral immune evasion pro-
teins inhibit DDX3′s function in anti-viral innate immunity, with the
consequence of suppressing type I IFN production. On the other
hand, DDX3 has also been shown to be an essential host factor for
the replication of several different viruses, most notably HIV and
HCV [90,91,131].
DDX3 was shown to be required for HIV replication and the export
of unspliced and partially spliced HIV RNAs from the nucleus [131].
These viral RNAs contain the so-called Rev-Responsive Element
(RRE) that is recognised by the HIV regulatory protein Rev. Rev con-
tains a leucine-rich nuclear export signal (NES) and binds to CRM1
(Chromosome Maintenance Region 1), the cellular export shuttle
protein that mediates export of NES-containing proteins [132]. Thus,
RRE-containing HIV RNAs are exported via the CRM1 pathway rather
than the main export pathway for fully spliced cellular mRNAs medi-
ated by the TAP (tip associated protein) export shuttle protein.
Export of RRE-containing HIV RNAs apparently also requires DDX3,
which was shown to bind to HIV Rev and CRM1 and to facilitate export
of RRE-containing HIV RNAs out of the nucleus [131]. The authors pro-
posed that DDX3 acts as an effector of CRM1-mediated transport rather
than mere cargo, as neither RanGTP binding nor the putative NES of
DDX3 were required for its binding to CRM1 [131]. On the other hand,
the ATPase and RNA unwinding activity of DDX3 were required for
HIV replication [131]. It was later confirmed in a separate study that de-
pletion of endogenous DDX3 using shRNA inhibits the export of HIV
RNAs and viral replication, while not affecting cell viability [133].
Essential cofactors of viral infections are interesting potential drug
targets, as it is thought that viruses will find it harder to evolve resis-
tance to drugs that target cellular host factors rather than viral proteins.
This is particularly relevant for HIV, as the emergence of resistance to
antiretroviral drugs poses a significant problemwith current HIV treat-
ment regimes. Several studies have already attempted to develop inhib-
itors for DDX3, mainly directed against its ATPase activity: Ring
expanded nucleoside analogues inhibiting the ATPase activity of DDX3
suppressed HIV replication without displaying any apparent cellular
toxicity [134]. Another group identified small molecule inhibitors of
DDX3's ATPase activity using pharmacophore modelling, and showed
that these were also able to block HIV replication [135,136]. A recent
study developed inhibitors targeting the RNA-binding interface of
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Fig. 1. The proposed roles of DExD/H-box helicases in anti-viral innate immune signalling. While the RIG-like helicases, RIG-I, mda5 and lgp2, have clearly defined roles in the sens-
ing of viral nucleic acids in the cytosol, the exact function of other DExD/H-box helicases is more ambiguous. DDX3 has been suggested to act as a sensor of viral dsRNA in conjunc-
tion with the RLHs, as a signalling intermediate downstream of TBK1 and IKKε and as a transcriptional regulator of the ifnb promoter. DDX60 has also been proposed to sensitize the
RLH to viral dsRNA ligands. DDX41 seems to sense cytoplasmic DNA and signal in a STING-dependent manner. DHX9 has been proposed to sense dsRNA and to signal in a
MAVS-dependent manner, and separately it was implicated in the response to CpG-B DNA where it signals through MyD88. A complex of DDX1, DDX21 and DHX36 has been sug-
gested to detect dsRNA and to signal via TRIF. DHX36 has also been shown to trigger IFN-α production in response to CpG-A DNA via a MyD88-dependent pathway.
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DDX3 and suppressed HIV replication in human PBMCs [137].
These studies suggest that DDX3 might indeed be a viable target
for the development of novel anti-HIV drugs. However, it is vital
that we understand more about the various cellular functions of
DDX3 and in particular the role of its ATPase activity, in order to de-
velop safe and specific strategies for targeting DDX3 therapeutically.
DDX3 was shown to interact with the Hepatitis C Virus (HCV) Core
protein, which forms part of the viral nucleocapsid [138–140]. While
the functional consequences of this interaction have still not been
fully established, it was more recently shown that DDX3 is required
for HCV replication [90,91]. However, it is still unclear whether the in-
teraction between DDX3 and the HCV Core protein is required for the
effect of DDX3 on HCV replication [141,142]. Expression of the HCV
Core protein induces a striking relocalisation of DDX3 in the cell, as it
strongly colocalises with the HCV Core protein [91]. This suggested
that sequestering of DDX3 by the HCV Core protein might disrupt
other cellular functions of DDX3. As mentioned in Section 2.2., it was
suggested that the HCV Core protein can affect the function of DDX3
in IFN induction [88,89].
In contrast to its role as an essential host factor in HCV replication,
DDX3 inhibited the replication of another hepatotropic virus, Hepatitis
B Virus. A study by Wang et al. showed that DDX3 interacts with HBV
polymerase, gets incorporated into nucleocapsids and inhibits viral re-
verse transcription [93]. As mentioned in Section 2.2., it has since also
been demonstrated that the HBV polymerase blocks the function of
DDX3 in innate immune signalling pathways leading to IFN induction[93,94]. Interestingly, in an analysis of human hepatocellular carcinoma
(HCC) samples, DDX3 levels were found to be reduced in HCC samples
from HBV-positive patients, while no reduction was observed in
samples from HCV-positive patients [143]. Hepatocellular carcinoma
(HCC) is a highly prevalent cancer in the modern world and is strongly
linked with hepatitis virus infection [144]. The above-mentioned study
linked DDX3 to the progression of cancer by showing that knockdown
of DDX3 led to early entry into S-phase and an increased growth rate
[143]. It was suggested thatwhile HBV downregulates DDX3 expression
(possibly to escape its inhibitory effect on viral reverse transcription),
HCV might disable DDX3 function through the Core protein interaction
[143]. Future research should clarify the mechanism by which DDX3
contributes to HCV replication and elucidate the functional conse-
quences of the Core protein-DDX3 interaction on viral replication and
HCV-mediatedpathological effects, such as thedevelopment of liver cir-
rhosis and HCC.
Recent studies suggested that DDX3 is also required for Norovirus
[145] and West-Nile Virus replication [146]. These findings might in-
dicate that a requirement of DDX3 for viral replication is a more uni-
versal feature of positive-stranded RNA viruses.
3.2. DDX1
Similar to DDX3, DDX1 has been shown to facilitate the nuclear ex-
port of Rev-dependent HIV RNAs [147]. Recent biochemical studies
showed that DDX1 promotes oligomerisation of Rev on the RRE
contained in Rev-dependent HIV RNAs [148]. DDX1 can bind to
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degree by free RNA or Rev-bound RNA [149]. These findings suggest
that DDX1plays a role in the assembly of Rev-RRE-RNA complexes, pos-
sibly preparing them for efficient export through the CRM1 pathway. It
would be interesting to address whether DDX1 and DDX3 have distinct
roles in HIV RNA export, as both of these helicases have been shown to
be involved in the export of Rev-dependent RNAs.
DDX1 was also shown to bind to the transcriptional control region
(TCR) of the John Cunningham (JC) Virus together with cleavage stimu-
lation factor (CstF). JC virus is a human polyomavirus, a dsDNA virus
that replicates in the nucleus, and can cause progressive multifocal
leukoencephalopathy (PML) in immunosuppressed patients. DDX1 ex-
pression promoted transcription of viral genes, while knockdown of
DDX1 led to reduced expression levels of JCV proteins [150,151].
DDX1 levels in cells were shown to correlate with permissiveness to
JCV infection, and exogenous expression of DDX1 restored susceptibility
to JCV infection.
DDX1 also interacts with Infectious Bronchitis Virus (IBV) non-
structural protein 14 (nsp14) and nsp14 of the SARS-Coronavirus [152].
Coronavirus nsp14proteins contain 3′-5′ exoribonuclease activity andap-
pear to be involved in ensuring a sufficient level of fidelity during the rep-
lication of the exceptionally large Coronavirus RNA genome [153]. Upon
IBV infection of Vero cells, DDX1 redistributed from the nucleus to the cy-
toplasm, where it colocalised with nsp14 and newly-synthesized viral
RNAs [152]. These findings suggest a role for DDX1 in genomic or
subgenomic coronavirus RNA replication or transcription, however only
a small effect on IBV replication in a cell culture system was found [152].
DDX1 was also found to associate with the HCV 3′(+)UTR and its
reverse complementary 5′(−)UTR. However, a role for DDX1 in HCV
replication could not be confirmed [154].
In summary, DDX1 appears to be recruited by several viruses with
different genomes and replication cycles. The exact function of DDX1 in
uninfected cells is unclear, but it appears to be involved in the 3′matura-
tion ofmRNAs [111,112]. It is an interesting observation that coronavirus
infection induced translocation of DDX1 from the nucleus to the cyto-
plasm [152], where it could conceivably form the DDX1-DDX21-
DHX36-TRIF complex that appears to be involved in the sensing of
dsRNA (see section 2.5) [11].
3.3. DHX9
DHX9 is another DExD/H-box helicase that appears to be an at-
tractive ‘prey’ for viruses, as there is ample evidence that it is required
for the replication of several different viruses. Interestingly, the struc-
ture of DHX9 is quite similar to that of the Flavivirus NS3 helicase
[155].
DHX9 is required for HIV replication [156] and appears to be in-
volved in several different steps of the HIV replication cycle. It was
shown to bind to the double-stranded stem of the HIV TAR leader
RNA and to enhance transcription from the HIV-LTR [157]. Phosphory-
lation by PKR within the N-terminal RNA binding domain reduced the
affinity of DHX9 for RNA and binding to the HIV TAR [109]. In a separate
study, DHX9 increased the levels of unspliced HIV CTE- and RRE-
containingmRNAs and was therefore proposed to release incompletely
spliced HIV RNAs from spliceosomes for export out of the nucleus [158].
DHX9 has also been suggested to facilitate export of RRE- and CTE-
containing viral RNAs through an alternative nuclear export pathway
mediated by the Sam68 cofactor and TAP [159]. There is increasing ev-
idence that DHX9 facilitates translation of HIV RNAs through binding to
the 5′UTR [160]. DHX9 has also been shown to be incorporated into HIV
virions by interacting with the HIV gag protein and HIV RNA. When
DHX9 was knocked down in virus producer cells, the resulting virions
were less infective and had a defect at the level of reverse transcription
[161]. Another recent study showed that DHX9 facilitates the annealing
of tRNA3Lys toHIV gagmRNA. The viral RNAwith its associated tRNA3Lys is
then incorporated into assembling virions [162]. As DHX9 has also beenshown to facilitate translation of gagmRNA [160], it appears that DHX9
can regulate two subsequent steps in the viral life cycle. The authors
suggested that DHX9 together with the HIV gag protein remodels the
viral RNAwhich switches it frombeing translated to being incorporated
into the newly assembling virions [162]. Thus, as stated above, DHX9
appears to be involved in virtually all steps regulating the expression
of HIV genes as well as the assembly of new virions. This is not incon-
ceivable, as other viral and cellular proteins that regulate transcription
or export of HIV RNAs, such as HIV Tat, HIV Rev, DDX3 and Sam68,
have also been shown to regulate translation of viral RNAs [86,163,164].
It still needs to be clarified whether DHX9 really independently af-
fects all of these different stages of HIV gene expression and replication.
However, if this is indeed the case, it suggests that DHX9might be an at-
tractive target for HIV (and other viruses) due to its multi-functionality.
DHX9 has also been shown to facilitate translation initiation in sever-
al other lymphotropic retroviruses. DHX9 interacted with the so-called
posttranscriptional control element (PCE), a stem-loop structure located
at the 5′end of retroviral (and some cellular) mRNAs. DHX9 is likely to
recognise common structural features of the PCE rather than a specific
RNA sequence and to promote translation by facilitating ribosome access
[165].
DHX9 was shown to be required for replication of Foot-and-mouth-
disease Virus (FMDV), a picornavirus. Upon FMDV infection, a striking
redistribution of DHX9 from the nucleus to the cytoplasm occurred
and DHX9 localised at sites of viral replication, where it associated
with the 5′terminus of the FMDV genome and viral proteins [166].
Similarly, DHX9 andotherNF/NFARproteinswere shown to associate
with the 5′ and 3′ termini of theHCV genomic RNA and to be required for
HCV replication [167]. Interestingly, this study also observed a nuclear to
cytoplasmic re-localisation of DHX9. Reminiscent of the proposedmech-
anism of DHX9 in HIV RNA translation and packaging [162], the authors
suggested that DHX9 is involved in creating a circular loop structure be-
tween the 3′ and 5′ termini of the genome which is required for coordi-
nating translation and replication of the HCV RNA [167].
DHX9 was also shown to be required for influenza virus replication
[168]. It interacted with the viral NS1 protein in an RNA-dependent
manner and enhanced viral RNA replication and transcription. Interest-
ingly, the study that implicated DHX9 as a sensor for dsRNA in myeloid
DCs showed that influenza virus-induced IFN-α production was re-
duced in cells after DHX9 knockdown (see section 2.4) [9]. This points
to a potentially very interesting dual function for DHX9, in that it
might bemediating IFN-induction in response to a virus that actively re-
cruits it to facilitate viral replication. On the other hand, the reduced
IFN-α production observed by Zhang et al. might also be a result of
decreased viral replication in the absence of DHX9, however viral repli-
cation was not assessed in this study [9].
3.4. Other RNA helicases involved in viral replication
DDX3, DDX1 and DHX9 are by no means the only DExD/H-box
helicases that are required for viral replication. A recent study identified
DDX5, DDX17 and DDX21 as HIV Rev-binding proteins and added them
to the long list of helicases that are required forHIV replication [130,169].
The P-body and stress granule component DDX6 was shown to be re-
quired for HIV-1, Foamy Virus, HCV and West Nile Virus replication
[170–173]. In many cases, a single virus appears to require multiple dif-
ferent cellular DExD/H-box helicases to facilitate different steps in its life
cycle [130]. This is likely to reflect the fundamental roles that DExD/
H-box helicases play in cellular and viral gene expression. Future studies
will undoubtedly add even more helicases to the long list of essential
host factors for different viruses.
3.5. Summary: RNA helicases as attractive viral targets
Many DExD/H-box helicases have been identified as essential host
factors for the replication of different viruses. Well studied viruses,
862 A. Fullam, M. Schröder / Biochimica et Biophysica Acta 1829 (2013) 854–865like HIV and HCV, appear to require a number of different cellular
helicases to facilitate their gene expression and replication. As DExD/
H-box helicases facilitate and coordinate cellular gene expression,
they also appear to be required to mediate the equivalent steps in
viral gene expression. In addition, they have also been shown to coordi-
nate the assembly of viral genomic RNA into newly assembling virions.4. Concluding remarks
As summarised in this review, DExD/H-box helicases appear to be
located at the frontline of the evolutionary arms race between viruses
and the host immune system. As ubiquitously expressed nucleic acid
binding proteins, they should be well-suited to detect invasion of viral
nucleic acid species. Due to intensive research over the years and recent
structural studies, we now have a good understanding of how the
RIG-like helicases selectively bind viral RNA ligands and trigger signal-
ling pathways in response. For other DExD/H-box helicases that have
recently been implicated in anti-viral immunity, these fundamental
questions remain to be addressed. In particular, it needs to be clarified
whether ‘sensing’ nucleic acids is their main role and if so, how exactly
they distinguish between cellular and viral nucleic acids. It will also be
interesting to investigate how they co-operate or intersect with other
nucleic acid sensing pathways. It might be worth considering whether
some of the helicases act as co-receptors or have (additional) down-
stream roles in anti-viral innate immune pathways.
DDX3, DHX9 and DDX1 have been implicated in anti-viral immunity,
yet are also required for the replication of several different viruses with
different genome organisation. This poses the question whether their
anti-viral signalling function has evolved in response to being ‘hijacked’
by viruses, or vice versa. In several cases, it has been shown that the sub-
cellular localisation of these helicases changed when they interacted
with viral RNA, namely from a primarily nuclear localisation to cytoplas-
mic viral replication sites. It might be this redistribution that allowed
them to come in contact with the adaptors mediating innate immune
pathways. Or have viruses evolved to primarily co-opt helicases that
are involved in anti-viral immunity, a strategy that would give them
the dual benefit of acquiring RNA unwinding activity while simulta-
neously disrupting anti-viral immune responses?Acknowledgements
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